02:43 PM EDT, 05/24/2024 (MT Newswires) -- Monopar Therapeutics ( MNPR ) said Friday it appointed Karthik Radhakrishnan as chief financial officer, starting July 1, to succeed Kim R. Tsuchimoto who will retire on June 30.

Radhakrishnan previously worked as CFO of Opexa Therapeutics, according to the company.

Price: 0.63, Change: +0.01, Percent Change: +1.45